Related Experiment Video
Updated: Aug 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors
S K Mitra1, D Mikolon, J E Molina
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract:
Elevated focal adhesion kinase (FAK) expression occurs in advanced cancers, yet a signaling role for FAK in tumor progression remains undefined. Here, we suppressed FAK activity in 4T1 breast carcinoma cells resulting in reduced FAK Y925 phosphorylation, Grb2 adaptor protein binding to FAK, and signaling to mitogen-activated protein (MAP) kinase (MAPK). Loss of a FAK-Grb2-MAPK linkage did not affect 4T1 cell proliferation or survival in culture, yet FAK inhibition reduced vascular endothelial growth factor (VEGF) expression and resulted in small avascular tumors in mice. This FAK-Grb2-MAPK linkage was essential in promoting angiogenesis as reconstitution experiments using Src-transformed FAK-null fibroblasts revealed that point mutations affecting FAK catalytic activity (R454) or Y925 phosphorylation (F925) disrupted the ability of FAK to promote MAPK- and VEGF-associated tumor growth. Notably, in both FAK-inhibited 4T1 and Src-transformed FAK-null cells, constitutively activated (CA) mitogen-activated protein kinase kinase 1 (MEK1) restored VEGF production and CA-MEK1 or added VEGF rescued tumor growth and angiogenesis. These studies provide the first biological support for Y925 FAK phosphorylation and define a novel role for FAK activity in promoting a MAPK-associated angiogenic switch during tumor progression.
Insights
Focal adhesion kinase (FAK) promotes tumor growth by enhancing angiogenesis through a MAPK signaling pathway. Inhibiting FAK reduces vascular endothelial growth factor (VEGF) and tumor vascularization, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Focal adhesion kinase (FAK) is upregulated in advanced cancers.
- The specific signaling role of FAK in tumor progression is not fully understood.
Purpose of the Study:
- To investigate the signaling role of FAK in tumor progression and angiogenesis.
- To define the contribution of FAK Y925 phosphorylation to tumor growth.
Main Methods:
- Suppressed FAK activity in 4T1 breast carcinoma cells.
- Utilized Src-transformed FAK-null fibroblasts for reconstitution experiments.
- Analyzed FAK Y925 phosphorylation, Grb2 binding, MAPK signaling, and VEGF expression.
- Employed constitutively activated MEK1 to rescue VEGF production and tumor growth.
Main Results:
- FAK inhibition reduced FAK Y925 phosphorylation, Grb2 binding, and MAPK signaling.
- FAK inhibition decreased vascular endothelial growth factor (VEGF) expression, leading to avascular tumors in mice.
- Mutations affecting FAK catalytic activity or Y925 phosphorylation impaired tumor growth and angiogenesis.
- Restoring MAPK signaling or VEGF rescued tumor growth and angiogenesis.
Conclusions:
- FAK activity, specifically Y925 phosphorylation, is essential for promoting angiogenesis via a MAPK-dependent pathway.
- FAK plays a novel role in driving the angiogenic switch during tumor progression.
- Targeting FAK could be a strategy to inhibit tumor angiogenesis and growth.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mechanism of Angiogenesis

